March 5, 2023
Tag: Lisa Carey
January 24, 2023
Medscape: Immune-Related Biomarkers Can Help Guide HER2+ Breast Cancer Tx
January 9, 2023
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 9, 2023
ASCO Post: Immune System B Cells May Help to Predict Treatment Response Among Patients With HER2-Positive Breast Cancer
January 6, 2023
Precision Oncology News: Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses
January 5, 2023
Medscape: Agents and Sequencing Decisions for HR+ Breast Cancer
January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
December 20, 2022
ASCO Post: Joannie M. Ivory, MD, MSPH, and Lisa A. Carey, MD, on PAM50 Subtype and 21-Gene Recurrence Scores in Younger and Black Women With Breast Cancer
December 6, 2022
UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium
UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.
November 22, 2022